DNTH holders · CITADEL ADVISORS LLC 13F · DNTH stock
CITADEL ADVISORS LLC Dianthus Therapeutics Inc. (DNTH) 13F holding
CITADEL ADVISORS LLC reported 1,610,483 DNTH shares valued at $135.2M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.
This is the newest DNTH 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the DNTH holders table.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 1,610,483 | $135.2M | COM |
| 2025-12-31 | 1,068,934 | $44.1M | COM |
| 2025-09-30 | 1,013,501 | $39.9M | COM |
| 2025-06-30 | 665,044 | $12.4M | COM |
Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.